Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Behavioral dysfunction in Parkinson's disease.

J H Friedman1

  • 1Brown University School of Medicine, Neurology Department, Memorial Hospital of Rhode Island, Pawtucket 02860, USA.

Clinical Neuroscience (New York, N.Y.)
|April 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammation and fatigue in early, untreated Parkinson's Disease.

Acta neurologica Scandinavica·2018
Same author

Thoughts on fatigue in Parkinson's disease (and other disorders).

European journal of neurology·2016
Same author

Multiple re-challenges for clozapine neutropenia in Parkinson's disease.

Parkinsonism & related disorders·2016
Same author

Parkinson disease psychosis: Update.

Behavioural neurology·2012
Same author

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

Neurology·2012
Same author

Is fatigue in early Parkinson's disease a minor inconvenience or major distress? The answer is 'Yes!'.

European journal of neurology·2012

Behavioral symptoms in Parkinson's disease (PD) significantly impact quality of life. While some symptoms like dementia are untreatable, others such as depression and psychosis show good response to medication.

Area of Science:

  • Neurology
  • Psychiatry

Background:

  • Behavioral symptoms in Parkinson's disease (PD) are often more debilitating than motor symptoms.
  • These symptoms can arise as primary disease manifestations or as drug-induced complications.

Purpose of the Study:

  • To discuss the phenomenology, pathology, and treatment of behavioral manifestations in Parkinson's disease.
  • To highlight treatable behavioral symptoms and those with limited therapeutic options.

Main Methods:

  • Review of existing literature on Parkinson's disease behavioral symptoms.
  • Discussion of pharmacological and non-pharmacological treatment approaches.

Main Results:

  • Dementia and abulia are significant challenges in PD management with currently limited treatment options.

Related Experiment Videos

  • Depression and psychosis in PD patients often respond favorably to available medications.

    • Conclusions:

    • Effective management of behavioral symptoms in Parkinson's disease requires a nuanced approach.
    • Targeted pharmacological interventions can significantly improve outcomes for specific behavioral manifestations like depression and psychosis.